Cisplatin nephrotoxicity in children after continuous 72-h and 3×1-h infusions

• Published in: Pediatric nephrology (Berlin, West) Vol. 16; no. 7; pp. 586 - 593
• Main Authors: Erdlenbruch, B., Pekrun, Arnulf, Roth, Christian, Grunewald, R. Willi, Kern, Wolfgang, Lakomek, Max
• Format: Journal Article
• Language: English
• Published: Heidelberg Springer 01.07.2001; Springer Nature B.V
• Subjects: Albumin; Biological and medical sciences; Children; Cisplatin; Drug toxicity and drugs side effects treatment; Excretion; Glomerular filtration rate; Glucosaminidase; Medical sciences; Pharmacokinetics; Pharmacology. Drug treatments; Platinum; Proteinuria; Toxicity: urogenital system; Human; Kidney disease; Antineoplastic agent; Urinary system disease; Intravenous administration; Continuous; Toxicity; Cisplatin; Kidney; Alkylating agent; Nephropathy; Reversibility; Pharmacokinetics; Child; Repetition; Platinum II Complexes
• ISSN: 0931-041X; 1432-198X
• DOI: 10.1007/s004670100610

Little is known about the association be- tween the rate of cisplatin administration and the severity of cisplatin-induced renal damage in children. The purpose of this study was to compare severity and reversibility of renal damage in children after continuous and repetitive bolus administration of cisplatin and to correlate these data with pharmacokinetic parameters. Study subjects included six children (ten courses) re-ceiving cisplatin as 1-h bolus infusions on three consecutive days (3×40 mg/m2) and four children (eight courses) receiving 72-h continuous infusions (120 mg/m2). In all courses, signs of glomerular and tubular damage were seen, as evidenced by elevated urinary excretion of α1-microglobulin, albumin and N-acetyl-β-d-glucosaminidase and decreased glomerular filtration rate (GFR). Comparing the two infusion regimens, the 1-h bolus administration of cisplatin was followed by significantly higher peak free platinum concentrations in plasma and urine (P<0.001), resulting in lower nadirs of the GFR (P<0.005). Correlations were found between both peak free platinum concentrations in plasma and urine and maxima of urinary albumin and N-acetyl-β-d-glucosaminidase excretion. Within 12 months after completion of cisplatin therapy, children in the 1-h bolus group had recovered only partially from subclinical nephrotoxicity, with five out of six showing pathological proteinuria. The results provide clear evidence that long-term ciplatin infusions are less nephrotoxic than repetitive bolus infusions. [PUBLICATION ABSTRACT]